00
003920.KO Namyang Dairy
- Market cap
- KRW 398B
- P/E
- 35.0x
- P/B
- 0.43x
- ROE
- 1.7%
- Dividend yield
- 0.21%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 003920.KO undervalued?
Graham number003920.KO trades 18.3% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Namyang Dairy fundamental analysis
No fundamental analysis for Namyang Dairy yet.
Namyang Dairy stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Namyang Dairy
Namyang Dairy Products Co., Ltd manufactures and sells dairy products in South Korea and internationally. It offers babies products under the Imperial Dream XO, Imperial Kid XO, Imperial Mom XO, I am Mother, Star Grow, Blood Crown, Koko Crown Picky Eater, Namyang KI PLUS PREMIUM, Namyang Shanyang Rufen, Hope Allegy, and Hope Doctor brands. It also provides coffee beverages and mixes, yogurt, beverages, cheese, raw and soyabean milk, and whipping cream and creamer; and Namyan…
Full company profileNamyang Dairy financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Namyang Dairy annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.23T | 1.17T | 1.08T | 1.03T | 949B | 956B | 965B | 997B | 953B | 914B | 966B |
| Gross Profit | 324B | 301B | 269B | 247B | 170B | 151B | 150B | 189B | 196B | 193B | 183B |
| Operating Income | 28.6B | 5.08B | 8.59B | 417M | -77.0B | -77.9B | 150B | -71.5B | -9.81B | 5.17B | 3.60B |
| EBITDA | - | 42.8B | 48.1B | 92.6B | -9.45B | -18.2B | -56.4B | -32.0B | 27.4B | 31.6B | 27.5B |
| Net Income | 37.2B | 5.02B | 2.02B | 29.2B | -53.5B | -58.9B | -78.4B | -66.2B | 250M | 7.11B | 15.7B |
| EPS | - | 7,387 | 2,965 | 43,005 | -78,710 | -86,641 | -92,460 | -9,747 | 40 | 1,207 | 2,661 |
| Balance Sheet | |||||||||||
| Total Assets | 1.04T | 1.04T | 1.05T | 1.06T | 998B | 937B | 902B | 780B | 724B | 1.10T | 1.08T |
| Total Liabilities | 152B | 141B | 164B | 144B | 138B | 124B | 164B | 112B | 92.4B | 146B | 157B |
| Shareholders' Equity | 889B | 895B | 889B | 912B | 861B | 813B | 738B | 667B | 632B | 949B | 925B |
| Cash & Short-term Investments | 96.5B | 83.6B | 79.4B | 70.2B | 64.8B | 119B | 79.6B | 61.0B | 85.3B | 42.1B | 21.4B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 121B | 12.0B | 42.6B | -11.1B | -49.4B | 38.4B | -57.6B | -38.3B | 34.8B | 26.9B | -38.1B |
| Capital Expenditure | 39.4B | 52.9B | 72.9B | 95.5B | 40.3B | 9.41B | 7.38B | 8.04B | 2.83B | 9.14B | 6.91B |
| Free Cash Flow | - | -41.0B | -31.0B | -107B | -89.8B | 28.8B | -65.0B | -46.3B | 31.9B | 17.7B | -45.0B |
| Ratios | |||||||||||
| ROE | 4.2% | 0.6% | 0.2% | 3.2% | -6.2% | -7.2% | -10.6% | -9.9% | 0.0% | 0.7% | 1.7% |
| ROA | 3.6% | 0.5% | 0.2% | 2.8% | -5.4% | -6.3% | -8.7% | -8.5% | 0.0% | 0.6% | 1.4% |
| Net Profit Margin | 3.0% | 0.4% | 0.2% | 2.8% | -5.6% | -6.2% | -8.1% | -6.6% | 0.0% | 0.8% | 1.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Namyang Dairy dividends
- Dividend yield
- 0.21%
- Forward dividend
- 1,428.00 KRW
- Payout ratio
- 11.8%
- Ex-dividend date
- Dec 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 836M | 142 | 11.8% |
| 2024 | KRW 890M | 142 | 355.9% |
| 2023 | KRW 856M | 126 | - |
| 2022 | KRW 854M | 1,007 | - |
| 2021 | KRW 854M | 1,257 | - |
| 2020 | KRW 855M | 1,257 | - |
| 2019 | KRW 855M | 1,258 | 2.9% |
| 2018 | KRW 855M | 1,258 | 42.4% |
| 2017 | KRW 855M | 1,257 | 17.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 10:1 on Nov 20, 2024.
Who owns Namyang Dairy
- Insiders 63.23%
- Institutions 0.96%
- Public & others 35.81%
- Shares outstanding 5.56M
- Free float 4.10M
Namyang Dairy company profile
- Company name
- Namyang Dairy
- Ticker
- 003920.KO
- ISIN
- KR7003920006
- Exchange
- Korea Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 1,495
- Fiscal year end
- December
- Address
- 240 Dosan-daero, Seoul, South Korea
- Phone
- 82 2 734 1305
- Website
- company.namyangi.com
About Namyang Dairy
Namyang Dairy Products Co., Ltd manufactures and sells dairy products in South Korea and internationally. It offers babies products under the Imperial Dream XO, Imperial Kid XO, Imperial Mom XO, I am Mother, Star Grow, Blood Crown, Koko Crown Picky Eater, Namyang KI PLUS PREMIUM, Namyang Shanyang Rufen, Hope Allegy, and Hope Doctor brands. It also provides coffee beverages and mixes, yogurt, beverages, cheese, raw and soyabean milk, and whipping cream and creamer; and Namyang KETONIA, a liquid formula for high-fat ketogenic dietary food for infants and young children, as well as real estate services. The company was founded in 1964 and is headquartered in Seoul, South Korea. Namyang Dairy Products Co., Ltd operates as a subsidiary of Hahn & Co. No. 19 Co., Ltd.
Namyang Dairy management
1- Woong KimChief Executive Officer · born 1953